Sections
Log in
Top News
U.S. News World News Featured Voices
Odd News
Entertainment
Movies Music TV
Sports
Soccer NFL NBA MLB NHL Golf Horse Racing Tennis Col. Football Col. Basketball
Photos
News Entertainment Sports Features Archives
More...
Defense Featured Science Health Archive Almanac
About Feedback
About Feedback
Search
Trending
National emergency
Jussie Smollett
Catholic abuse
Venezuela
Valentine's turnips
India
Baby death
'Domestic terrorist'
Largest jeans
Tanner crabs
Ralph Northam
Health News
Jan. 18, 2019 / 12:19 PM

New test may catch pancreatic cancer in earlier stages

By
Tauren Dyson
Pancreatic cancer is detected by calculating the level of sugar it produces that leaks into the bloodstream. Photo by toeytoey/Shutterstock

Jan. 18 (UPI) -- A new pancreatic cancer test could detect the disease before it progresses to later, deadly stages, new research says.

Scientists have developed tests that pinpoints close to 70 percent of pancreatic cancer with less than 5 percent false-positive rate, according to a study published this month in Clinical Cancer Research.

"Pancreatic cancer is an aggressive disease made even more devastating by its tendency to spread before detection, which is a serious roadblock to successful medical treatment," Brian Haab, a professor at the Van Andel Research Institute and the study's senior author, said in a press release. "We hope that our new test, when used in conjunction with the currently available test, will help doctors catch and treat pancreatic cancer in high-risk individuals before the disease has spread."

Pancreatic cancer often occurs without early symptoms, making it hard to diagnose. Once doctors finally discover the disease, it's in an advanced stage making it harder to treat. In fact, the survival rate for patients with pancreatic cancer is 8.5 percent.

RELATED Ruther Bader Ginsburg to miss second week on Supreme Court

The American Cancer Society says pancreatic cancer accounts for 3 percent of all cancers and 7 percent of all cancer deaths in the U.S.

Pancreatic cancer is detected by calculating the level of sugar it produces that leaks into the bloodstream. The new test, however, measures a sugar called sTRA, which comes from a different subset of pancreatic cancers. The traditional test, which measures a sugar known as CA-19-9, only confirms a pancreatic cancer diagnosis.

Developed 40 years ago, the CA-19-9 test only detects 40 percent of pancreatic cancers, and its only practical use is to track the progression of the disease. When used in combination, both the sTRA and CA-19-9 tests work effectively to locate the disease in its early stages.

RELATED Exercise may help increase cancer patient's chance for survival, study says

"We believe using these tests in a complementary fashion will help physicians detect pancreatic cancers much sooner in the disease process, which significantly improves a patient's chance for survival," Haab said. "Right now, there are few options for people suspected to have pancreatic cancer. This combined blood test could be a simple, cost-effective way to detect disease early enough to improve patient outcomes."

RELATED Scientists working on breath test to detect cancers
Follow us on Facebook, Twitter and Instagram for more UPI news and photos.

Trending Stories

Report: The number of cancer survivors grows as oncologists dwindle
Teens view anxiety, depression as biggest problems in lives, study says
Study links sleep apnea, daytime drowsiness to heart disease
Alzheimer's breakthrough may come from bone marrow experiment with mice
Food allergy linked to certain form of eczema, study says

Photo Gallery

 
The 1975, Dua Lipa walk Brit Awards red carpet

Latest News

Dust devil travels down New Zealand road
Syrian Democratic Forces turn over 150 captured IS fighters to Iraq
Clever boy uses doorbell camera to get help from dad
IMF approves $4.2B extended fund facility for Ecuador
New recommendation could cut costly UTI tests in half, study says
 
Back to Article
/
Back to top
About UPI Contact Feedback Advertisements Submit News Tips
Copyright © 2019 United Press International, Inc. All Rights Reserved.
Terms of UsePrivacy Policy